22 julio 2015
An important new target for ovarian cancer therapy has been identified by scientists. Contrary to current research, this new study found that LKB1 is an important molecule in the cancer’s promotion and survival. Their research definitively shows that ovarian cancer cells still have LKB1 and that this molecule allows ovarian cancer spheroids to change their metabolism, promote tumor cell survival and make them more resistant to chemotherapy.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/nb9wyIuLc1s» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/nb9wyIuLc1s/150722101841.htm
